Search results
138 results found
Where next for ctDNA liquid biopsy in the NHS?BlogCirculating tumour DNA (ctDNA) testing, also known as liquid biopsy, hit the headlines in 2020 with the announcement that GRAIL’s Galleri test – a test that aims to detect cancer early – will be trialled in the NHS.
Personalising therapy for age-related macular degenerationBlogGene therapy holds new hope for patients with age-related macular degeneration. If successful they will be beneficial to patients for whom no current therapies are available or do not work.
Using signs and symbols to improve the care of people with dementiaBlogHospital teams often need to quickly identify patients with e.g. dementia who may have extra care needs. But these tools can pose ethical dilemmas.
Are we ready for earlier breast cancer screening?BlogA guest blog from Prof Dr Marjanka Schmidt principal investigator and coordinator of the B-CAST project.
Further genetic clues to severe COVID-19BlogNew research published in Nature has revealed important genetic causes of the most severe forms of COVID-19 disease.
A new era for vaccine development?BlogThe approval of this mRNA-based vaccine could herald a new era for vaccine design and efficacy.
Functional genomics: an application for rare disease?BlogFunctional genomics uses data from genomics and other ‘omics technologies to better understand how genes work and the implications for human health.
Moving forward with breast cancer preventionBlogBetter understanding of the why, how and who of breast cancer, combined with new technologies, are creating opportunities for personalised prevention
Pathogen genomics initiative to boost disease control in AfricaBlogAfrica Pathogen Genomics Initiative to strengthen laboratory networks and public health surveillance across Africa
Genetic and immune basis of severe COVID-19 cases revealedBlogNew research has uncovered the biological basis for some severe COVID-19 cases, revealing the importance of interferon in effective anti-viral responses